These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Rhabdomyolysis and unexplained malaise. Role of combination of ciprofibrate and norfloxacin]. Blain H; Klein M; Weryha G; Tréchot P; Hanesse B; Leclère J Rev Med Interne; 1996; 17(10):859-60. PubMed ID: 8976986 [No Abstract] [Full Text] [Related]
16. Fibrate-induced increase in blood urea and creatinine. Lipscombe J; Bargman JM Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661 [No Abstract] [Full Text] [Related]
17. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment. Ramachandran S; Giles PD; Hartland A BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186171 [No Abstract] [Full Text] [Related]
18. Creatinine rise after fibrate therapy in renal graft recipients. Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C Lancet; 1993 Mar; 341(8848):840. PubMed ID: 8096050 [No Abstract] [Full Text] [Related]
19. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. Mikhailidis DP; Jagroon IA Metabolism; 2001 Nov; 50(11):1385-6. PubMed ID: 11715936 [No Abstract] [Full Text] [Related]
20. CORONARY EFFECT OF FIBRATES ON PROTEINS AND ENZYMES WHICH HYDROLYZE TRIACYLGLYCEROLS. Francik R; Kryczyk J; Francik S Acta Pol Pharm; 2016; 73(3):579-88. PubMed ID: 27476274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]